SEC Filings | Biora Therapeutics, Inc.

Filing date	Form	Description	Filing Group	View
November 30, 2020	CORRESP	CORRESP	Other	View HTML 0001193125-20-305955.pdf 0001193125-20-305955.rtf 0001193125-20-305955.xls
November 30, 2020	CORRESP	CORRESP	Other	View HTML 0001193125-20-305960.pdf 0001193125-20-305960.rtf 0001193125-20-305960.xls
November 20, 2020	8-K	Report of unscheduled material events or corporate event	Current reports	View HTML 0001193125-20-299439.pdf 0001193125-20-299439.rtf 0001193125-20-299439.xls
November 18, 2020	8-K	Report of unscheduled material events or corporate event	Current reports	View HTML 0001193125-20-297063.pdf 0001193125-20-297063.rtf 0001193125-20-297063.xls
November 17, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000899243-20-031294.pdf 0000899243-20-031294.rtf 0000899243-20-031294.xls
November 13, 2020	UPLOAD	UPLOAD	Other	View HTML 0000000000-20-010884.pdf 0000000000-20-010884.rtf
November 10, 2020	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Registration statements	View HTML 0000950123-20-011151.pdf 0000950123-20-011151.rtf 0000950123-20-011151.xls
November 9, 2020	8-K	Report of unscheduled material events or corporate event	Current reports	View HTML 0001564590-20-052529.pdf 0001564590-20-052529.rtf 0001564590-20-052529.xls
November 9, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly filings	View HTML 0001564590-20-052554.pdf 0001564590-20-052554.rtf 0001564590-20-052554.xls EX-101.INS - XBRL INSTANCE DOCUMENT
October 29, 2020	8-K	Report of unscheduled material events or corporate event	Current reports	View HTML 0001193125-20-280467.pdf 0001193125-20-280467.rtf 0001193125-20-280467.xls

Data provided by Kaleidoscope.